We have found that Western blots (WBs) of whole platelets exposed to normal autologous or homologous sera commonly have bands at 90 to 95 (95) Kd, and less often at 100 to 110, 80 to 85, 60 
EACTIONS OF alloantibodies with Western blots
R (WBs) of platelets have been a reliable basis for diagnosing neonatal and posttransfusion disorders, identifying new platelet alloantigen systems, and defining glycoproteins (GPs) that contain specific epitopes. WB techniques also have been used to identify apparent antiplatelet autoantibodies in sera of thrombocytopenic patients with a variety of disorders, including systemic lupus erythematosus (SLE),' idiopathic thrombocytopenic purpura (ITP),2-6 acquired immunodeficiency syndrome (AIDS),' sepsis,' posttransfusion purpura: and drug purpura." However, in the process of screening sera of similar groups of patients for antiplatelet antibodies, we found that control normal sera often produce WB reactions resembling those reported as hallmarks of autoimmune disease. In addition, antiglobulin reagents alone produce bands that have been noted p r e v i o u~l y ,~~~~~~'~'~~' ' but are not well-characterized. We have evaluated experimental parameters of WB assays that affect the number and intensity of bands and have concluded that controls for normal sera and antiglobulins have often been inadequate. For this reason, some WB patterns previously interpreted as evidence of autoimmunity may represent quantitative variations of normal rather than qualitatively pathologic reactions. Normal autologous or homologous immunoglobulins (Igs) were found to react in 85% of instances with a 90 to 95-Kd internal platelet protein, and less commonly with proteins of 100 to 110, 80 to 85, 60 to 75, and 50 to 60 Kd. We have established the differences that distinguish the 95-Kd protein from other platelet proteins of similar molecular weight.
IGBINDING PLATELET PROTEINS 2195
100,000 x g for 30 minutes to remove the Triton-insoluble fraction, concentrated, and subjected to protein determination.
Hetastarch, 6% in 147 mmol/L NaCl containing 0.03% sodium citrate (American McGaw, Irvine, CA) was added to citrated whole blood in a ratio of 1 part per 8 parts whole blood. Red blood cells (RBCs) were sedimented by gravity and WBCs in the supernatant plasma were pelleted by centrifugation at 170 x g for 10 minutes and washed three times with normal saline (NS). Differential counts indicated 50% to 60% polys, 40% to 50% lymphs, and 1% platelets. Protein was measured before WBCs were solubilized in electrophoresis treatment buffer (see platelet preparations) and stored at -7OOC.
GPIII, preparations. Solubilized platelet membranes were applied to a Concanavalin A-Sepharose 4B column (Pharmacia, Piscataway, NJ).I3 Triton X-100 was removed by washing the column with 0.1% CHAPS (Pierce), a detergent that does not absorb at 280 nm, in PBS. The column was eluted with 10% a-methyl-Dmannopyranoside (Sigma) and the eluate was dialyzed versus PBS-EDTA buffer with 0.1% SDS, applied to a Sephacryl S-300 column (Pharmacia), and fractions containing a single band at 85 to 90 Kd (GPIII,) by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (7.5% T) were stored at -7OOC.
IgG from serum of a normal donor containing 95 Kd-reactive IgG that titered 1,280 (dilution-') was prepared by chromatography using CM-Affigel Blue (BioRad, Richmond, CA) and Protein A-tris-acryl (Pierce) matrices, following manufacturer's instructions. The purified IgG was digested with Immobilized Pepsin (Pierce) at pH 4 for 4 hours at 37OC with constant agitation. F(ab'), fragments were separated from residual IgG by sequential passage over Sephacryl S-300, Protein A-tris-acryl, and anti-human F, affinity columns, the latter prepared by coupling anti-F, (Caltag, South San Francisco, CA) to a Reacti-Gel 6-X activated resin (Pierce) per manufacturer's instructions. SDS-electrophoresis of the final product showed a single band at 120 Kd by Coomassie staining, and an immunoblot assay in which 30 pg of F(ab'), were loaded per lane was free of IgG. The lowest quantity of IgG detectable by this immunoblot assay was approximately 10 ng.
Bicinchoninic acid (BCA) reagent was used according to the manufacturer's directions (Pierce). Standards consisted of solutions of bovine serum albumin (BSA) (Fraction V, Sigma) in PBS (with or without detergent) having concentrations ranging from 0.03 to 2.0 mg/mL. IgG and F(ab'), proteins were also quantitated specifically by microtiter sandwich enzyme immunoassays (EIAs).
Microtiter plates (Immulon I, Dynatech, Chantilly, VA) were coated with goat anti-human IgG, y chain-specific (Kirkegaard & Perry Laboratories [KP], Gaithersburg, MD), 750 ng/well in 100 pL of coating buffer. The coating, washing, and blocking buffers were prepared from stock reagents contained in an ELISA MateTM kit (KP). Plates were blocked with buffer containing 1.0% BSA. Samples, diluted in blocking buffer, were incubated for 60 minutes at room temperature; plates were washed three times; and alkaline phosphatase-conjugated goat anti-human IgG, y-specific (KP), was applied. After 60 minutes, plates were washed three times, pnitrophenyl phosphate substrate in diethanolamine buffer (KP) was added, and absorbance measured with a Dynatech MR 650 plate reader. Sensitivity was linear in the 2 to 65 ng range. All samples and controls were done in triplicate.
Fresh, washed platelets (1 x 109/mL) in PBS-EDTA were incubated with or without 5 U/mL human thrombin (Sigma), final concentration, at 37OC for 60 minutes. Without centrifugation, samples were immediately solubilized, electrophoresed, transferred to nitrocellulose, and developed after exposure to normal serum. In a separate experiment, 5 x lo9 fresh washed platelets in PBS-EDTA were exposed to thrombin (5 U/mL) or saline for 30 minutes at 37OC, pelleted at 1,700 x g for 10 minutes, and the supernatants were passed through a 0.2-pm filter. The quantity of 95-Kd protein present in filtrates was determined by WB titration and compared with that in a 0.2-pm filtrate of an equal number of the same platelets lysed by sonication and freeze-thawing (see mechanical lysis of platelets).
Discontinuous SDS-PAGE was performed according to the method of Laemmli14 on a BioRad Mini Protean I1 electrophoresis cell. Unless otherwise stated, resolving gels contained 7% T acrylamide and had dimensions of 8 x Protein blotting was performed according to the guidelines of Burnette" using 0.45-pm pore nitrocellulose paper (Schleicher & Schuell, Keene, NH) on a BioRad Mini-Transblot cell with a modified buffer containing 10% methanol, at constant current of 150 mA for 2 hours or 90 mA overnight. Dried blots were stored at 4OC in zip-lock bags up to 1 month before development.
Nitrocellulose strips were subjected to the following sequential manipulations on a rocker platform using 5 mL of reagent per strip: (1) Nonspecific protein blocking for 60 minutes; solutions in PBS tested included 1% gelatin, 1% normal goat serum. 0.5% BSA Pentex Fraction V (Miles), and Blotto,I6 a 5% nonfat dry milk solution, containing 0.01% antifoam A emulsion (Sigma). Diffuse background color was least with Blotto, but otherwise the results were the same. (2) Sixty-minute incubation with test serum diluted in Blotto; (3) two five-minute Blotto washes; (4) sixty-minute incubation with biotin-labeled affinity-purified goat anti-human IgG, -IgA, or -IgM, heavy chain specific (KP) diluted 1/330 in Blotto. This dilution was chosen after comparing dilutions from 1/100 to 1/500 for line clarity and interfering background color. (5) Two Blotto washes; (6) sixty-minute incubation with KP peroxidaselabeled streptavidin (SP) diluted 1/330 in Blotto; (7) two blotto washes; (8) one rapid wash (5 to 10 seconds) with PBS to remove any residual, undissolved particles of milk; (9) color development with a 1:l mixture of 4-chloro-1-napthol and hydrogen peroxide (4CN-H,O,), both supplied by KP; (10) quick rinse with PBS; (11) air drying on filter paper and rapid photography to record faint bands.
Other reagents that were tested and found to give nearly indentical results to the KP biotinylated antiglobulin reagent at comparable dilutions were biotinylated goat anti-human IgG, F(ab'), fragment, y specific (Tago, Burlingame, CA) and horseradish peroxidase (HRP0)-labeled goat anti-human IgG, F, specific, (Caltag). Reagents used for the assay to determine purity of the human F(ab'), preparation were sheep anti-human IgG, F(ab'), specific antibody A total of 1.5 x IO7 fresh salinewashed platelets were incubated with test sera diluted 1/10, 1/100, and 1/1,000 in a total volume of 0.5 mL of PBS-5 mmol/L EDTA-0.5% BSA for 60 minutes, washed once, incubated 60 minutes with fluorescein-labeled goat y-specific anti-human IgG (FITC-anti-IgG, KP) diluted 1/500 in the same buffer, washed once, and then resuspended in 0.5 mL buffer. Cell fluorescence was measured in a Becton Dickinson Fluorescence Activated Cell Sorter (FACS; Mountain View, CA).
Aliquots, 2.0 mL, of one normal serum containing IgG reactive in a titer of 320 with the 95-Kd protein were Electrophoresis.
WE analysis.
Immunofluorescence studies.
Adsorption studies.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From exposed for I hour at 37OC to 8 x IO* platelets that had k e n freshly washed and pellaed. In addition. 2 mL of the same normal serum was mixed with an equal volumeof the initial supernatant of 4 x IO' lysed platelets after it had been filtered through a 0.2-rm filter. Adsorbed aliquots were titered by serial dilution against WBs of whole platelets obtained from the donor of the scrum.
Platclct-amxiated IgG (PAIgGI measurement. P A I S detmninations were performed according to the technique of Hotchkiu et al" using microliter EIA rather than RIA to quantitate IgG. Serum samples obtained concurrently were titrated for 95 Kd-reactive IgG. Both rhesus and baboon sera produced 95-Kd bands, each with titers of 100. when anti-human IgG was used as the second antibody. were found in 3596.30 to 50 in 30%. 100 to 320 in 15%. and 640 to 1.280 in 5%. Individuals maintained the same titer from year to year Over 3 to 5 years based on multiple sampling of high-and low-titered donors. Serum could be stored for more than 2 years without change in titer. Reactions of Sera with platelets were not influenced by AB0 type of the donor from which serum or platelets were obtained.
RESULTS

Reactions of
F(ab'), prepared from IgG of a normal reactive serum (titer 640) elicited the 95-Kd band in WB analysis (see Fig  3) . A minimum concentration of 31 pg F(ab'), mL was The cytosolic fraction of mechanically lysed platelets, filtered through a 0.2-pm filter after centrifugation at 61.500 x g to remove sedimentable components, contained 80% to 90% of the 95-Kd protein (see Fig 4) . Minimum material required to produce the 95-Kd band with either mechanically lysed or glycerol-loaded and hypotonically lysed platelets was the filtered supernatant from 7.5 to IO x IO6 platelets, or the sedimented membranes from 4 to 7.5 x io' platelets. In adsorption tests. no change in the initial titer of 320 occurred when 8 x IO' fresh platelets were preincubated with 2 mL serum. whereas the soluble supernatant fraction of only 4 x IO' lysed platelets reduced the 95 Kd-reactive IgG titer of 2 mL of serum to 80. IgG reactions with the 95-Kd protein could not be detected on the platelet surface. when IO normal sera with reactive titers up to 1.280 were used in FACS studies (see Fig 5) . Qiferences between known glycoproteins and the 9s-Kd protein. On WBs of normal (or thrombasthenic) platelets electrophoresed under reduced conditions. the 95-Kd protein did not change in apparent molecular weight (see Fig 6 , right panel). Its mol wt did not direr on gelsof varying acrylamide percentages as often occurs with GPs of high carbohydrate content." Thrombasthenic platelets that contained no GP-111, by either silver stain analysis of reduced and nonreduced SDS-polyacrylamide gels or by anti-PI"' and anti-PI"' reactions on nonreduced WBs, produced a 95-Kd band of similar intensity to normal platelets when exposed to serum containing both anti-PI "I and 95 Kd-reactive lgGs (compare lanes 1 and 2 in Fig 6) . The mol wtsof GPIII, and the 95-Kd protein are so close that a strong band indicating reaction with one may obscure a weaker reaction with the other (see the 90 + 95-Kd doublet in Fig 6, lane 3) . A titration of normal versus thrombasthenic platelets exposed to one concentration of normal serum (Fig 7) further indicates that thrombasthenic platelets contain at least 50% as much 95-Kd protein as normals. Moreover. no reaction was obtained when WBs of purified GPIII, (20 pg per lane) were exposed to normal sera that produced high titer 95-KD lines with WBs of whole platelets (data not shown).
Blots of Bernard-Soulier (Bs) platelets exposed to a reactive normal serum had the 95-Kd band. The minimum quantity necessary for this reaction was approximately I .2 x IO' platelets/lane. which was similar to that of normal platelets although the BS platelets lack GPV."." The supernatant of platelets treated with more than enough thrombin to completely hydrolyze GPV" and the supernatant of intact platelets incubated in saline both contained only about 1% of the 95-Kd protein in the supernatant of mechanically lysed platelets. Lysates of thrombin-treated platelets contained normal amounts of 95-Kd protein.
Patterns on WBs of platelets exposed to sera of various patients kfore development with anti-IgG. Sera from IO patients with chronic stable ITP (platelet counts ranging from 3.000 to 60.000/pL), 5 patients with acute quinidineor quinine-purpura (counts c 10.000/pL). 3 patients with human immunodeficiency virus associated thrombocytopenia (HIV-TP counts 5.OOO to 71.000/pL). I patient with thrombocytopenia due to myelodysplasia (20.000/pL). splenectomy. Of the three. two had ITP with platelet counts of c5.000/rL before splenectomy. rising to stable counts of 35,000/rL and 400.000/rL. respectively. The third patient with HIV-TP rose from <5.000/rL before to 250.000/rL after splenectomy.
PA/&.
PAlgGs of six normals ranged from 0.42 to 0.79 fg/platelet. and respective 95 Kd-reactive titers ranged from 0 to 640. PAlgGs of thrombocytopenic patients (4 with ITP, 2 with HIV-TP. and I with myelodysplasia, having platelet a u n t s of 8.000 to l00,0oO), ranged from 1.6 to 13.7 fg/platelet and 95 Kd-reactive titers. from 0 to 1.OOO. There was no correlation between PAlgG values and 95 Kdreactive IgG titers. Table 2 summarizes reports in which WB analyses have been used exclusively to identify apparent platelet-specific autoantibodies that were considered responsible for thrombocytopenic disorders. Our studies suggest that some platelet W B reactions reported as evidence of autoimmunity may not differ qualitatively from certain antiglobulin background reactions or from reactions of normal serum Igs with intracellular platelet proteins.
DISCUSSION
Reactions of antiglobulin reagents alone with platelet
WBs. Antiglobulin background bands are due to epitopes on PAlg molecules or their derivatives because: (1) WBs of purified Igs loaded in quantitiesequivalent to total PAlgs"."" have patterns identical to background patterns of platelet WBs (see Fig I) ; (2) preincubation of an antiglobulin reagent with the respective purified Ig blocks development of all background bands; (3) F(ab), preparations of antiglobulin reagents elicit the same background bands as whole IgG preparations, indicating that the bands do not represent IgG bound to platelet F, receptors.
In addition to antiglobulin background bands, normal sera incubated with platelet blots before development with antiglobulins produced bands with varying frequency at 100 to 1 IO. 90 /I Presumed to be GPV.
(Binding not drug-dependent.
#90 Kd = PIA1: 140 Kd = GPllb.
homosexuals; ARC, AIDS-related complex.
IgA in SO%, and by IgM in 30%. Purified IgG prepared commercially from pooled human plasma (when used instead of serum) produced the 95-Kd band, but not the less commonly seen bands. Of normal sera that contained 95 Kd-reactive IgG (85% of those tested), 65% had titers between 10 and 50. There were no unusual characteristics notable among the normal donors who titered greater than 50 or the few with titers of 640 and 1,280; and titers, whether high or low, did not change significantly on sequential sampling over a period of several years.
Because the 95-Kd bands are obtained with equal intensity when serum is exposed to autologous and homologous blotted platelets, alloantibodies are not responsible for these reactions. Moreover, none of the observed lines produced by normal sera were in the range of the 45-Kd human leukocyte antigen heavy chain GP.24 The 60 to 65-Kd bands observed with some sera did vary in intensity with WBs prepared from different platelets, but we have not evaluated this reaction in detail.
Because the most common WB pattern produced by normal sera involved Igs binding to a 95-Kd platelet protein, we further characterized this reaction. (Fig 4) . Attempts to detect the 95-Kd protein by adsorption or immunofluorescence studies indicated that it was not present on the platelet surface (Fig 5) . Therefore platelet eluates, often used as sources of antibodies, will not contain all of the normal serum Igs reactive with platelet proteins on WB. Platelet membranes prepared by glycerol loading and hypotonic lysis are associated with approximately 10% to 15% of the 95-Kd protein, suggesting that the protein may be loosely bound to internal membranes or associated with unruptured or resealed vesicles. The protein is not in secretory granules that can be released by thrombin. It is apparent that the age and physical state of platelets (ie, whole, partially lysed, or purified membranes) used for WB preparations will influence the number and intensity of bands obtained with normal or pathologic sera.
In routine WBs, reactions of the 95-Kd protein may be mistaken for GPIII,. However, the 95-Kd protein differs from GPIII, in many respects: (1) it is present primarily in For personal use only. on September 14, 2017. by guest www.bloodjournal.org From cytosol, not on external membranes; (2) its mol wt is slightly greater than that of GPIII,; (3) reducing agents do not affect its mol wt (see Fig 6) ; (4) its mol wt on gels of varying percentages of acrylamide is more constant than that of GPIII,, possibly reflecting low carbohydrate content of the 95-Kd protein''; (5) thrombasthenic (GT type I) platelets contain it in similar amounts to normal platelets (Fig 7) ; (6) Igs that bind to it do not react with purified GPIII, on WBs; and (7) it does not react with specific anti-GPIII, alloantibodies.
GPIV, which has a mol wt of 97 Kd that is unaltered by reducing agents,25 could be confused with the 95-Kd protein on the basis of mol wt measurements alone, but it is only present on external platelet membranes.
GPV, identified by some investigators as a target antigen in various thrombocytopenic disorders (see Table 2 ), has a reported mol wt of 82 to 89 Kd.22,26 It is an external membrane protein that is lost from platelets within 72 hours of venipuncture.26 Findings indicating that the 95-Kd protein is not GPV are: (1) washed normal platelets stored in saline for 72 hours contain approximately 80% to 90% of the quantity of 95-Kd protein found in fresh platelets; (2) thrombin treatment that removes 100% of GPV from platelets by hydrolysis22 does not diminish the 95-Kd protein; and GPIII, has been reported to bind IgG and F(ab'), on the platelet surface in relatively small amounts compared with the ability of GPIII, to bind anti-PIA'.'' This has been postulated to be due to an alteration of GPIII, resulting in a senescent antigen. However, there are no reports of normal Igs reacting in WB with GPIII,.
Titers of 95 Kd-reactive IgG, IgA, and IgM in individual sera were not necessarily similar (data not shown). For example, sera containing a reactive IgG could have higheror lower-titered or unmeasurable reactive IgA or IgM.
Sera from 86% of a group of patients with various thrombocytopenic disorders produced 95-Kd bands on platelet WBs. Identical results using thrombasthenic and reduced platelets indicate that GPIII, was not involved in these reactions. Titers of 95 Kd-specific IgG were 2 5 0 in 57% of these sera, compared with 17% of normal donors. However, there is no correlation between titer of 95 Kd-reactive IgG and severity of thrombocytopenia. Severe thrombocytopenia occurred with titers less than 10 and mild thrombocytopenia with titers greater than 100.
Several investigators have found that elevated PAIgGs in
Reactions of pathologic sera.
various thrombocytopenic disorders are at least partially due to nonspecific or nonpathologic IgG, IgA, and/or IgM.30.3' Conceivably, the internal Ig-binding proteins may foster accumulation of normal platelet Igs in injured platelets, but we found no correlation between serum titers of 95 Kdreactive IgG and PAIgG values of platelets from the same samples. We and others find that PAIgG is increased in stored platelet^,^^.^^ but it remains to be determined whether binding of Igs by internal proteins is responsible.
A large percentage of autoantibodies identified previously by WB in sera from thrombocytopenic patients ( Table 2) react with platelet protein(s) in the 80 to 95 Kd and 120 Kd mol wt range, similar to the mol wt ranges of common reactions with normal Igs. For example, serum autoantibodies directed against GPV (80 Kd) at titers 2100 have been described in all of six patients tested with quinidine purpura," and an autoantibody directed against a 120-Kd protein was described in the acute serum of one patient with PTP.' However, we found that 4 of 5 patients with quinidine/ quinine purpura reacted only with the 95-Kd protein, and none of sera from five different acute phase PTP patients had a 120-Kd band stronger than background bands commonly seen. Controls in most studies usually involved serum dilutions of 1/50 or 1/100, which would decrease the frequency of positive 95-Kd reactions. However, in one study' where a 1/10 dilution of pooled normal AB serum was used for a control, an 86-Kd band was observed that appeared to be due to a cytoplasmic platelet protein, and may be identical to the 95-Kd band we have described.
The fact that titers of 95 Kd-reactive IgGs can vary widely among normals from less than 10 to greater than 1,280, and tend to remain unchanged within a particular individual over a period of years makes a physiologic role for these proteins seem unlikely. However, identification of intracellular Igbinding proteins in a cell that secretes but does not produce Igs suggests possible relevance of these proteins to incorporation of Igs into a gran~les~'-~' and other PAIg phenomena.
The 95-Kd Ig-binding protein is of special interest in that an analogy can be drawn between it and bacterial proteins such as Staphylococcal Protein A (SPA) and Streptococcal Protein G (SPG) that react nonspecifically with human Igs of varied isotype (SPA) and subclass (SPG), as well as with Igs from several species of animals (both SPA and SPG). The bacterial proteins bind primarily to the Fc portion of Igs, but have also been clearly shown to have some reactivity with F(ab'), fractions of I~s.'*,~' Whether the 95-Kd platelet protein reacts nonspecifically with more restricted isotypes and subclasses of Igs than does SPA or SPG, or whether the reaction is immunospecific, remains to be determined.
Significance of Ig-binding platelet proteins.
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